Summary
The results of a follow-up study of 112 patients with multiple myeloma are presented. Three of these patients developed acute leukaemia during the respective period of clinical observation (maximum: 11 years) — one case of acute myeloblastic leukaemia, myelomonocytic leukaemia and erythroleukaemia, myelomonocytic leukaemia and erythroleukaemia, respectively. For estimating the incidence of acute leukaemia in the presence of multiple myeloma an extended life table method was applied. On the basis of our data this method gave a probability of 5.9% for a patient to develop acute leukaemia at any time after the diagnosis of multiple myeloma. In a statistical discussion this result is considered to confirm the assumption of a highly increased AL-risk in patients with multiple myeloma. In a survey of the literature some important data of 100 cases with the association acute leukaemia — multiple myeloma are reported.
Zusammenfassung
Es werden die Ergebnisse einer Follow-up-Studie vorgelegt, in deren Rahmen insgesamt 112 Plasmozytom-Patienten maximal 11 Jahre lang unter klinischer Beobachtung standen. 3 Patienten entwickelten innerhalb des Beobachtungszeitraumes eine akute Leukämie. Hierbei handelte es sich um je einen Fall von akuter myeloblastischer Leukämie, myelomonozytärer Leukämie und Erythroleukämie. Zur Schätzung der Inzidenz von akuter Leukämie bei Ausgangsbefund Plasmozytom wird eine erweiterte Sterbetafelmethode benutzt. Aus unseren Daten erhielten wir hiermit als Wahrscheinlichkeit, daß bei einem Plasmozytompatienten irgendwann im weiteren Krankheitsverlauf eine akute Leukämie auftritt, die Zahl 5,9%. Dieses Ergebnis wird auf Grund einer ausführlichen methodischen Diskussion als Hinweis auf ein stark erhöhtes AL-Risiko bei Plasmozytom-Patienten gewertet. In einer Literaturübersicht werden wichtige Daten von 100 Fällen mit der Assoziation von Plasmozytom und akuter Leukämie zusammengestellt.
Similar content being viewed by others
Literatur
Alexanian, R., Balcerzak, S., Haut, A., Hewlett, J., Gehan, E.: Remission maintenance therapy for multiple myeloma. Arch. Intern. Med.135, 147 (1975)
Allgemeine Sterbetafel 1970/72. Wirtschaft und Statistik26, 392 (1974)
Andersen, E., Videbaek, A.: Stem cell leukaemia in myelomatosis. Scand. J. Haematol.7, 201 (1970)
Anker, E.: Akutt myelogen leukemi ved myelomatose. T. Norske Laegeforen.4, 175 (1977)
Arseneau, J.C., Sponzo, R.W., Lewin, D.L., Schnipper, L.E., Bonner, H., Young, R.C., Canellos, G.P., Johnson, R.E., De Vita, V.T.: Non-lymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy. N. Engl. J. Med.287, 1119 (1972)
Begemann, H.: Klinische Hämatologie. S. 642. Stuttgart: Thieme 1970
Beltran, G., Stuckey, W.J.: Bone marrow ultrastructure in myelongenous leukemia associated with multiple myeloma. 14th International Congress of Hematology, Sao Paulo 1972 (Abstract 540)
Bergsagel, D.E.: The treatment of plasma cell myeloma. Br. J. Haematol.33, 443 (1976)
Brown, I.N., Berenbaum, M.C.: Inhibition of immune processes by Melphalan. Nature201, 1340 (1964)
Cardamone, J.M., Kimmerle, R.J., Marshall, E.Y.: Development of acute erythroleukemia in B-cell immunoproliferative disorders after prolonged therapy with alkylating drugs. Am. J. Med.57, 836 (1974)
Cavalli, F., Gerber, A., Mosimann, W., Sonntag, R.W., Tschopp, L.: Akute myeloische Leukämie im Krankheitsverlauf des Morbus Hodgkin. Dtsch. Med. Wochenschr.102, 1019 (1977)
Chiang, C.L.: A stochastic study of life table and its applications III. The follow-up study with the consideration of competing risks. Biometrics17, 57 (1961)
Chiang, C.L.: Introduction to Stochastic Processes in Biostatistics. New York: John Wiley & Sons 1968
Cohen, S.L., Dodsworth, H., Whitelaw, A.G.L.: Leukaemia on myeloma. Br. Med. J.1971IV, 490
Costa, G., Engle, R.L., Jr., Schilling, A., Carbone, P., Kochwa, S., Nachman, R.L., Glidewell, O.: Melphalan and Prednisone: An effective combination for the treatment of multiple myeloma. Am. J. Med.54, 589 (1973)
Cutler, S.J., Ederer, F.: Maximum utilization of the life table method in analyzing survival. J. Chronic Dis.8, 699 (1958)
Cywiner-Golenzer, C., Adotti, F., Marsan, C., Quillard, A., Henon, Ph., Grimaldi, A., Dryll, A.: Myélome, Melphalan et leucémie aigue myélo-monocytaire. Sem. Hôp.50, 207 (1974)
Dahlke, M.B., Nowell, P.C.: Chromosomal abnormalities and dyserythropoiesis in the preleukaemic phase of multiple myeloma. Br. J. Haematol.31, 111 (1975)
Dubosky, D., Jacobs, P.: Acute leukaemia and myeloma. Lancet1974I, 1113
Dunn, C.D.R.: Possible role of the immune response in the stem cell depression produced by Melphalan. J. Nat. Cancer Inst.52, 181 (1974)
Edwards, G.A., Zawadzki, Z.A.: Extraosseous lesions in plasma cell myeloma. Am. J. Med.43, 194 (1967)
Fishman, S.A., Ritz, N.D.: Erythroleukemia following Mephalan therapy for multiple myeloma. N.Y. St. J. Med.75II, 2402 (1975)
Goldfarb, S.B., C.R. Bishop: IgD myeloma and acute myelomonocytic leukemia. Blood49, 489 (1977)
Gonzales, F., Trujillo, J.M., Alexanian, R.: Acute leukemia in multiple myeloma. Ann. Intern. Med.86, 440 (1977)
Holland, J.F.: Epidemic acute leukemia. N. Engl. J. Med.283, 1165 (1970)
Hollard, D., Muller, J.M., Leger, J., Denis, M.B.: Association myélome, leucose myeloide et lymphosarcome. Reflections nosologiques. Lyon Méd.213, 967 (1965)
Holt, J.M., Robb-Smith, A.H.T., Callender, S.T., Spriggs, A.I.: Multiple myeloma-development of alternative malignancy following successful chemotherapy. Br. J. Haematol.22, 633 (1972)
Holt, J.M., Spriggs, A.: Zitiert nach Rosner und Grünwald [51]
Hossfeld, D.K., Holland, J.F., Cooper, R.G., Ellison, R.R.: Chromosome studies in acute leukemias developing in patients with multiple myeloma. Cancer Res.35, 2808 (1975)
Van Hove, W., Hamers, J., Demeulenaere, L.: Acute leukaemia in myeloma. Lancet1973II, 570
Karchmer, R.K., Amare, M., Larsen, W.E., Mallouk, A.G., Caldwell, G.G.: Alkylating agents as leukemogens in multiple myeloma. Cancer33, 1103 (1974)
Kardinal, C.G., Barnes, A., Pugh, R.P.: Acute leukemia: A disease of medical progress? Missouri Med.71, 683 (1974)
Khaleeli, M., Keane, W.M., Lee, G.R.: Sideroblastic anemia in multiple myeloma: A preleukemic change. Blood41, 17 (1973)
Kyle, R.A., Pierre, R.V., Bayrd, E.D.: Multiple myeloma and acute myelomonocytic leukemia. N. Engl. J. Med.283, 1121 (1970)
Kyle, R.A., Pierre, R.V., Bayrd, E.D.: Multiple myeloma and acute leukemia associated with alkylating agents. Arch. Intern. Med.135, 185 (1975)
Labedzki, L., Fuchs, H.J., Grips, K.H.: Plasmozytom und finale unreifzellige Leukose. Dtsch. Med. Wochenschr.101, 108 (1976)
Law, I.P., Plovnick, H.S., Beddow, D.G.: Multiple myeloma, sideroblastic anemia and acute leukemia. N. Engl. J. Med.294, 164 (1976)
Ligorsky, R.D., Baker, L.H., Carmel, R.: Multiple myeloma. J. Am. Med. Ass.231, 347 (1975)
Marcović, N., Hansson, B.G., Hällén, J.: Myelomatosis and acute monocytic leukaemia. Scand. J. Haematol.12, 32 (1974)
Meytes, D., Katz, D.R.: Breast cancer and acute leukemia in a patient with multiple myeloma treated with Melphalan. Isr. J. Med. Sci.9, 1044 (1973)
Mills, R.C., Cornwell, G.G., McIntyre, O.R.: Remission of leukemia associated with multiple myeloma. N. Engl. J. Med.285, 920 (1971)
Niskanen, E., Vuopio, P.: Akuutti leukemia multippelin myelooman yhteydessä. Duodecim91, 1026 (1975)
Nordenson, N.G.: Myelomatosis. A clinical review of 310 cases. Acta Med. Scand. Suppl.445, 178 (1966)
Ohta, H., Ikeda, Y., Shibata, T., Hirabayashi, N.: A case of multiple myeloma terminating with acute myelomonocytic leukemia after long-term melphalan therapy. Acta Haematol. Jpn.37, 49 (1974)
Osserman, E.F.: Monocytic and monomyelocytic leukaemia with increased serum and urine lysozyme as a late complication in plasma cell myeloma. Br. Med. J.1971 II, 327
Osserman, E.F., Lawlor, D.P.: Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J. Exp. Med.124, 921 (1966)
Parker, A.C.: A case of acute myelomonocytic leukaemia associated with myelomatosis. Scand. J. Haematol.11, 257 (1973)
Quirt, I.C., Hart, G.D., Soots, M.: Leukaemia on myeloma. Br. Med. J.1972I, 248
Reimer, R.R., Hoover, R., Fraumeni, J.F., Young, R.C.: Acute leukemia after alkylating-agent therapy of ovarian cancer. N. Engl. J. Med.297, 177 (1977)
Riedler, G.F., Vorburger, E., Maier, C.: Unreifzellige Leukosen und Myelom. Schweiz. Med. Wochenschr.102, 1592 (1972)
Rosner, F., Grünwald, H.: Multiple myeloma terminating in acute leukemia. Am. J. Med.57, 927 (1974)
Rosner, F.: Acute leukemia as a delayed consequence of cancer chemotherapy. Cancer37, 1033 (1976)
Scamps, R.A., O'Neill, B.J., Newland, R.C.: A case of multiple myeloma terminating with acute myelomonocytic leukaemia. Med. J. Aust.1971II, 1129
Schmalzl, F., Keiser, G., Kresbach, E., Fritz, H., Asamer, H., Braunsteiner, H.: Plasmozytom, Alkylantien und akute myelogene Leukämie. Dtsch. Med. Wochenschr.100, 1961 (1975)
Sieber, S.M., Adamson, R.H.: Maintenance therapy in myeloma: Risk versus benefit. Br. Med. J.1975I, 557
Skinnider, L.F., Ghadially, F.N.: Ultrastructure of acute myeloid leukemia arising in multiple myeloma. Hum. Path.6, 379 (1975)
Taddeini, L., Schrader, W.: Concomitant myelomonocytic leukemia and multiple myeloma. Minn. Med.55, 446 (1972)
Tursz, T., Flandrin, G., Brouet, J.C., Seligmann, M.: Coexistence d'un myélome et d'une leucémie granuleuse en l'absence de tout traitement. Nouv. Rev. Franc. Hémat.14, 693 (1974)
Videbaek, A.: Unusual cases of myelomatosis. Br. Med. J.1971II, 326
Webb, J.A.W., Bateman, C.J.T., Davies, J.D.: Leukaemia on myeloma. Br. Med. J.1971IV, 231
Wintrobe, M.M.: Clinical Haematology. p. 1618. Philadelphia: Lea & Febiger 1974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bierbach, H., Zeile, G., Wellek, S. et al. Akute Leukämie bei multiplem Myelom. Klin Wochenschr 57, 769–777 (1979). https://doi.org/10.1007/BF01478035
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01478035